Product Information
LEVOTHYROXINE 125 MCG TABLET is a generic product labeled by Mylan Institutional LLC, priced at $0.0570 per EA under NDC 51079044320. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3,AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 ug/1
Manufacturer
Mylan Institutional LLCNDC
51079044320
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA076187FDA Approved
6/5/2002
TE Code
AB1,AB2,AB3,AB4
On Market Since
2/5/2007
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 125 MCG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 81.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0570 per EA |
|---|---|
| All-time high | $0.5269 (Sep 10, 2014) |
| All-time low | $0.0545 (Jul 17, 2024) |
| 52-week high | $0.0665 |
| 52-week low | $0.0569 |
| Median price | $0.3363 |
| Average price | $0.3008 |
| Largest weekly change | +57.9% (Jun 19, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Institutional LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levothyroxine sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
l-Thyroxine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 125 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 125 MCG TABLET, manufactured by Mylan Institutional LLC, is $0.0570 per EA (NDC 51079044320), effective Sep 30, 2026.
How has the price of LEVOTHYROXINE 125 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 125 MCG TABLET has declined 81.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 125 MCG TABLET?
Since Nov 28, 2013, the NADAC for LEVOTHYROXINE 125 MCG TABLET has ranged from a low of $0.0545 (Jul 17, 2024) to a high of $0.5269 (Sep 10, 2014), with a median of $0.3363 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 125 MCG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 125 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 125 MCG TABLET?
LEVOTHYROXINE 125 MCG TABLET (NDC 51079044320) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.